Precipitated Withdrawal After a Buprenorphine Induction
A 32-year-old woman with fentanyl use disorder presents at 6 a.m. requesting buprenorphine. She reports last fentanyl use 18 hours ago. Her Clinical Opiate Withdrawal Scale score is 9, driven mainly by anxiety, yawning, and restlessness. She takes sertraline 100 mg daily and smokes cannabis. The emergency physician gives buprenorphine 8 mg sublingually. Forty-five minutes later she is agitated, drenched in sweat, vomiting, and having profuse diarrhea. Pupils are dilated, blood pressure 158/96 mmHg, heart rate 118/min, temperature 37.8°C, and she is pacing and demanding to leave. Urine immunoassay is positive for fentanyl, benzodiazepines, and cannabis. There is no tremor, clonus, or hyperreflexia.
1. What is happening, what else must you consider, and what should you do - and not do - in the next hour?
Read the worked answer
This is precipitated withdrawal, not an allergic reaction or a new intoxication. Buprenorphine's high affinity but partial agonism displaces full agonists from mu receptors; when receptor occupancy is high from fentanyl, the net effect is an abrupt drop in agonism 30–60 minutes after the dose. The picture fits: autonomic surge, gastrointestinal symptoms, mydriasis, agitation, and onset at the expected time after dosing.
Differential to exclude actively: serotonin syndrome from sertraline (would show clonus, hyperreflexia, hyperthermia - absent here), stimulant intoxication (no stimulant on the immunoassay, and the diarrhea and vomiting fit withdrawal), sedative-hypnotic withdrawal (benzodiazepine positive, but onset is usually later and tremor and seizures dominate), and acute anxiety or panic.
Do: stop further buprenorphine; move to a quiet, monitored space; give clonidine 0.1–0.2 mg (or dexmedetomidine if monitored) for autonomic symptoms; ondansetron for vomiting; IV fluids; an NSAID; short-term benzodiazepine only for severe agitation, used cautiously and documented. Reassure her explicitly that this is time-limited and expected.
Do not: give naloxone - it will worsen the withdrawal dramatically and has no role. Do not give repeated large buprenorphine doses to "push through," and do not discharge her mid-crisis without a plan, because she is at high risk of return to use and overdose.
2. Once she is comfortable, how would you complete induction? Compare waiting and retrying, microdosing, and methadone, including what is different about fentanyl.
Read the worked answer
The choice depends on how much withdrawal she is willing to tolerate and what the local system can support.
Wait and retry: allow the precipitated withdrawal to resolve (often 6–24 hours, occasionally longer), then restart at a low dose - 2 mg, not 8 mg - and reassess at 60–90 minutes, adding 2 mg increments only when withdrawal is clearly present. This is the most familiar approach but requires her to stay engaged through a miserable interval, which is exactly when patients leave.
Microdosing (Bernese-style): begin buprenorphine at 0.5 mg once or twice daily while continuing a full agonist, escalating over about a week before tapering the full agonist. It avoids precipitated withdrawal and is attractive after a failed induction. It requires a prescriber comfortable with the protocol, reliable follow-up, and a full agonist she can actually obtain - fentanyl from the unregulated supply is unpredictable in potency, which undercuts the schedule.
Methadone: full agonists do not precipitate withdrawal, so this is the most reliable option for someone who has failed buprenorphine. In the United States this means an opioid treatment program with daily dosing and its own access barriers.
Why fentanyl matters: it is highly lipophilic with a large volume of distribution and can produce delayed and prolonged withdrawal. A standard 12–24 hour pre-induction waiting period, or a score of 9 on a scale weighted toward anxiety, may not reflect adequate receptor emptying. Using a higher withdrawal threshold and starting low is the practical safeguard.
3. She stabilizes and wants to leave. What will you arrange before discharge, and what documentation matters?
Read the worked answer
Discharge against advice is a likely outcome and should be treated as a handoff, not a failure.
Before she leaves:
- Give take-home naloxone with a demonstration, and explain that tolerance has fallen.
- Offer a same-day or next-day buprenorphine or methadone appointment; a warm handoff to a bridge clinic beats a phone number.
- Provide a written plan for what precipitated withdrawal feels like and what to do if it recurs, including the instruction not to take a large dose to compensate.
- Treat nausea and give clonidine if not contraindicated; screen for pregnancy and offer testing, since that changes the risk calculus.
- Ask directly about suicide risk and about the possibility that the "benzodiazepine" result reflects a counterfeit pill, which is a strong marker of high-risk supply.
Documentation: vital signs and serial withdrawal scores before and after dosing; the dose, route, and timing of buprenorphine; the reasoning that distinguished precipitated withdrawal from serotonin syndrome and intoxication; what was offered and refused; the naloxone provided; and the referral made. Record the immunoassay result with a note that it is presumptive and does not confirm the specific benzodiazepine or exclude fentanyl analogues. This documentation protects the patient's future care and makes the clinical reasoning visible to the next clinician.